A company still losing money with growing sales.
Facts from SEC filings, not a recommendation.
From MXL's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.
Last 12 months: -$29.4M.
Move the sliders to your own view of MXL. Starting points are the company's recent numbers (it isn't profitable yet, so the margin starts at a 10% guess).
What today's price needs: with a 10% margin and a 15x P/E, sales would have to grow about 57% a year for 5 years just to match today's price.
Simple math on your guesses, not a forecast or a price target. Real results depend on many things these sliders leave out.
Price chart by TradingView.
From annual reports filed with the SEC. A checklist is a starting point for research, not a verdict.
No open-market insider buys or sells in the last 90 days.
No trades to chart yet.
SEC filings of any kind. 50 means a normal week.
Institutions cut 1.9% from their holdings. 311 bought, 133 sold.
No open-market buys or sells in 90 days. Grants and option exercises are left out.
"Owns after" is the insider's holding right after the trade. Pre-planned (10b5-1) sales are set up months ahead, a weaker signal.
1,110 shares
591,454 shares at $85.27 avg ($83.31 to $88.16) · $50.4M
11,000 shares at $105.00 · $1.2M
Source: SEC EDGAR filings. For informational purposes. Not investment advice.
Report a problem with this page